ELITE PHARMACEUTICALS INC /NV/ reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Northvale, NJ
SEC filing record 1 source field available
Fiscal year end
31 March
ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

SEC filing history

Showing 676-700 of 753 matching filings.

Per page
25
Current page
28
SC 13D File 005-59693

SCHEDULE 13D

Filing date
13 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-59693

SCHEDULE 13D

Filing date
11 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-15697

CT ORDER filing

Filing date
02 May 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
5

PRIMARY DOCUMENT

Filing date
29 Apr 2011
Reporting date
30 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
28 Apr 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
28 Apr 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
28 Apr 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
28 Apr 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

PRIMARY DOCUMENT

Filing date
28 Apr 2011
Reporting date
30 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q/A File 001-15697

10-Q/A filing

Filing date
26 Apr 2011
Reporting date
30 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Apr 2011
Reporting date
11 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
07 Apr 2011
Reporting date
06 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
07 Apr 2011
Reporting date
04 Apr 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K filing

Filing date
06 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
04 Apr 2011
Reporting date
31 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-15697

8-K

Filing date
17 Mar 2011
Reporting date
11 Mar 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .